Title: E-Daily– LegoChem applies for preliminary evaluation for special IPO.

Publication: E-Daily                                                 

Date: 01 October 2011

Summary

• LegoChem Bioscience applied for preliminary evaluation and will continue to prepare for special IPO in KOSDAQ.

• LegoChem is a qualified company for New Growth Engine special IPO evaluation. The company signed IPO supervision contract last year and passed the technology evaluation this year.

To view the full article (in Korean), click here ▶

About LegoChem Biosciences

LegoChem Biosciences, Inc. (LCB) is a research-based biotechnology company dedicated to discovering, developing, and commercializing innovative medicines by leveraging our chemistry expertise to make conventional biologics targeted and more potent for the benefit of patients with diseases of high unmet medical needs. We are advancing sustainable pipelines in therapeutic areas in antibiotics, anti-coagulants, oncology, antibody-drug conjugate (ADC), and protein-drug conjugate (PDC).